No Data
No Data
As DexCom (NASDAQ:DXCM) Lifts 7.5% This Past Week, Investors May Now Be Noticing the Company's One-year Earnings Growth
Wells Fargo Sticks to Their Buy Rating for Dexcom (DXCM)
Unusual Options Activity: C, SCHW and Others Attract Market Bets, C V/OI Ratio Reaches 52.6
ISRG, LLY, or DXCM: Which "Strong Buy" Healthcare Stock Has the Highest Upside Potential?
Earnings Preview: DexCom to Report Financial Results Post-market on May 01
Phenomix Sciences and Mayo Clinic to Present Landmark Research at DDW 2025, Advancing Precision Obesity Medicine